ASCO 2021: Presentations about whole genome sequencing

At the congress of the American Society of Clinical Oncology (ASCO) on 4-8 June 2021 researchers Kris Samsom and Luuk Schipper of the Dutch Cancer Institute (NKI) have presented their findings on whole genome sequencing.

In the poster presentation

Whole Genome Sequencing (WGS) is feasible in routine clinical care

Kris Samsom of the Dutch Cancer Institute explains the results of their research in which they conclude that WGS is feasible in routine diagnostics.

In the poster presentation

Whole Genome Sequencing (WGS) improves sarcoma diagnosis and patient care

Luuk Schipper of the Dutch Cancer Institute explains how they came to the conclusion in their research that WGS can help improve the diagnosis and the treatment of patients with sarcomas.

More information

You read an article in the category Scientific publications. You may also be interested in Whole genome sequencing.
All news

Also read

SAGE: New algorithm for analysis of tumor DNA reveals mutations previously not found

SAGE: New algorithm for analysis of tumor DNA reveals mutations previously not found

23-07-2020

At Hartwig we “analyse sequenced tumor DNA”. This is something we try to continuously improve. These analyses are shared with …

GLOW: working toward more treatment options for glioblastoma

GLOW: working toward more treatment options for glioblastoma

23-05-2023

The outlook for patients with glioblastoma has been unfavorable for years, and treatment options remain limited. That is a reason …

Unraveling of genetic mechanism behind tumor formation may improve targeted treatment for cancer patients

Unraveling of genetic mechanism behind tumor formation may improve targeted treatment for cancer patients

11-08-2022

Genetic alterations in the FGFR2 gene occur in various cancer types and represent a promising target for therapies. However, clinical …

Would you like to be kept up to date with new developments?

Sign up for our newsletters

Want to know more about the complete DNA test?

Visit OncoAct.nl